Literature DB >> 29194480

Clinical trial registry alone is not adequate: on the perception of possible endpoint switching and P-hacking.

Micah J Hill1, Matthew T Connell1, George Patounakis2.   

Abstract

Mesh：

Year:  2018        PMID： 29194480      PMCID： PMC6251575          DOI： 10.1093/humrep/dex359

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  3 in total

1.  Clinical trial registration in fertility trials - a case for improvement?

Authors:  Cynthia M Farquhar; Marian G Showell; Emily A E Showell; Penny Beetham; Nora Baak; Selma Mourad; Vanessa M B Jordan
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

2.  Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.

Authors:  Ali Abbara; Channa N Jayasena; Georgios Christopoulos; Shakunthala Narayanaswamy; Chioma Izzi-Engbeaya; Gurjinder M K Nijher; Alexander N Comninos; Deborah Peters; Adam Buckley; Risheka Ratnasabapathy; Julia K Prague; Rehan Salim; Stuart A Lavery; Stephen R Bloom; Matyas Szigeti; Deborah A Ashby; Geoffrey H Trew; Waljit S Dhillo
Journal:  J Clin Endocrinol Metab       Date:  2015-07-20       Impact factor: 5.958

3.  A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.

Authors:  Ali Abbara; Sophie Clarke; Rumana Islam; Julia K Prague; Alexander N Comninos; Shakunthala Narayanaswamy; Deborah Papadopoulou; Rachel Roberts; Chioma Izzi-Engbeaya; Risheka Ratnasabapathy; Alexander Nesbitt; Sunitha Vimalesvaran; Rehan Salim; Stuart A Lavery; Stephen R Bloom; Les Huson; Geoffrey H Trew; Waljit S Dhillo
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.